Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1973;48:959-970

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GIARDINA, E.-G. V.
Right arrow Articles by BIGGER, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GIARDINA, E.-G. V.
Right arrow Articles by BIGGER, J. T., Jr.

(Circulation. 1973;48:959.)
© 1973 American Heart Association, Inc.


Procaine Amide Against Re-Entrant Ventricular Arrhythmias

Lengthening R-V Intervals of Coupled Ventricular Premature Depolarizations as an Insight into the Mechanism of Action of Procaine Amide

ELSA-GRACE V. GIARDINA M.D.1 J. THOMAS BIGGER Jr. M.D.1

1 From the Departments of Medicine and Pharmacology, College of Physicians and Surgeons, Columbia University, and the Cardiac Intensive Care Unit of the Presbyterian Hospital in the City of New York, New York, New York.

Nine patients with coupled ventricular premature depolarizations (VPDs) were treated with intravenous procaine amide to abolish the arrhythmia. The effect of procaine amide on the electrocardiogram was carefully observed. Seven patients were treated with intermittent intravenous therapy-100 mg of procaine amide was injected every five minutes-and two were treated by constant intravenous infusion-200 µg/min/kg body weight; blood for plasma procaine amide concentration was obtained 4.5 to 5 min after each dose. As the cumulative dose of procaine amide increased, plasma drug concentration increased and the frequency of coupled VPDs progressively decreased. Moreover, in every patient an interesting electrocardiographic phenomenon was observed: as plasma drug concentration increased, the coupling interval progressively increased until the arrhythmia was completely abolished. A hypothesis for procaine amide's antiarrhythmic action is offered based on this new observation. This hypothesis suggests that procaine amide prolongs conduction in the depressed portion of a re-entrant pathway such that conduction is further delayed and block finally occurs, thereby terminating the arrhythmia.


Key Words: Plasma procaine amide concentration • Antiarrhythmic drugs • Two compartment drug model • Computer analysis of arrhythmias

Submitted on February 23, 1973
Accepted on July 13, 1973




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
E. J. Stanek, M. D. Schoen, and J. L. Bauman
Issues in the Treatment of Ventricular Ectopy: Past, Present, and Future Controversy
Journal of Pharmacy Practice, January 1, 1990; 3(5): 283 - 294.
[PDF]